Erik Amble serves as Executive at Axonics Modulation Technologies, Inc., where they oversee executive responsibilities. Since joining the company, Erik Amble has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 24, 2020 involved receiving (via award) 3,500 shares valued at $0.
Erik Amble currently holds 12,667 shares of Axonics Modulation Technologies, Inc. (AXNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Erik Amble has been a net neutral trader of AXNX stock. They have purchased $0 and sold $0 worth of shares.
Erik Amble's most recent insider trade was on Aug 24, 2020, when they sold 3,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 27, 2019 | AXNX | $0 | Award | 1,667 | $N/A | Discretionary |
| Dec 6, 2018 | AXNX | $0 | Award | 2,500 | $N/A | Discretionary |
| Nov 2, 2018 | AXNX | $0 | Conversion | 455,610 | $N/A | Discretionary |
| Nov 2, 2018 | AXNX | $0 | Conversion | 243,750 | $N/A | Discretionary |
| Nov 2, 2018 | AXNX | $0 | Conversion | 369,786 | $N/A | Discretionary |
| Nov 2, 2018 | AXNX | $0 | Conversion | 451,738 | $N/A | Discretionary |